Download Files:
Products Details
Product Description
– IVMT-Rx-3 is a inhibitor of SDCBP targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin. IVMT-Rx-3 blocks MDA-9/Syntenin interaction with Src, reduces NF-κB activation, and inhibits MMP-2/MMP-9 expression. IVMT-Rx-3 inhibits Melanoma Metastasis[1]</sup.
Web ID
– HY-156247
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C69H90F3N13O24
References
– [1]Pradhan AK, et al. Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis. Mol Cancer Ther. 2023;22(10):1115-1127.
Molecular Weight
– 1542.52
SMILES
– O=C(O)C(F)(F)F.O=C1N2N=C(N=C2NC3=C1CCC3)C(NC4=C(C=C(C(C)=C4)NC(CCOCCOCCOCCOCCOCCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)C(C)C)=O)CC5=CC=C(C=C5)O)=O)CC6=CC=C(O)C=C6)=O)CCC(O)=O)=O)CC(N)=O)=O)[C@@H](C)O)=O)=O)C)=O
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– MMP;NF-κB
Pathway
– Metabolic Enzyme/Protease;NF-κB
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
